Abstract
Analysis of the structure of CA125 is essential for determining the physiological role of this significant tumor antigen. The objectives of this study were: (1) to identify the characteristics of the CA125 isolated from healthy and patient women with epithelial ovarian cancer; and (2) to determine the ferning structure of this antigen. The cancer-derived CA125 antigen (cCA125) purified by gel filtration and affinity chromatography (Concanavalin A) was run on SDS-PAGE and examined using light microscopy and compared with healthy-derived CA125 antigen (hCA125). Both purified antigen cCA125 and hCA125 showed a high molecular mass (> 2,000 kDa) with high mannose glycans. The ferning patterns related to cCA125 and hCA125 revealed distinct differences in the patterns of arborescence. The ferning morphology of cCA125 antigen was denser than that of hCA125 antigen making an obvious difference between cCA125 and hCA125, with respect to length, branching and distribution of crystals. The current study provides the first evidence for a potential functional link between CA125 and its structure which, in the light of a comparison between cCA125 and hCA125, might proof to be of significant biomedical importance in the future.
Similar content being viewed by others
References
Yin BWT, Lloyd KO (2001) Molecular cloning of the CA125 ovarian cancer antigen. Identification as a new mucin, MUC16. J Biol Chem 276:27371–27375
JrRC B, Feeney M, Lazarus H et al (1981) Reactivity of a monoclonal antibody with a human ovarian carcinoma. J Clin Invest 68:1311–1337
Nustad K, Onsrud M, Jansson B et al (1998) Warren CA 125—epitopes and molecular size. Int J Biol Markers 13:196–199
Hanisch FG, Uhlenbruck G, Dienst C et al (1985) CA125 and CA 19–9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk. Eur J Biochem 149:323–330
Wong NK, Easton RL, Panico M et al (2003) Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J Biol Chem 278:28619–28634
Bouanène H, Miled A (2010) Conflicting views on the molecular structure of the Cancer Antigen CA125/MUC16. Dis Markers 28:1–10
Spiro RG (1972) Study of the carbohydrates of glycoproteins. Method Enzymol 28:3–43
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities utilizing the principal of protein dye binding. Anal Biochem 72:248–254
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Bouanène H, Harrabi I, Ferchichi S et al (2007) Factors predictive of elevated serum CA125 levels in patients with epithelial ovarian cancer. B Cancer 94:E18–E22
Bouanène H, Hadj Kacem H, Ben Fatma L et al (2010) Polymorphisms in the MUC16 Gene: Potential Implication in Epithelial Ovarian Cancer. Pathol Oncol Res (Epub ahead of print)
Lloyd KO, Yin BWT, Kudryashov V (1997) Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody VK-8: identification as a mucin- type molecule. Int J Cancer 71:842–850
Yu YH, Schlossman DM, Harrison CL et al (1991) Coexpression of different antigenic markers on moieties that bear CA 125 determinants. Cancer Res 51:468–475
Davis HM, JrVR Z, JrRC B et al (1986) Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res 46:6143–6148
Milutinovic B, Jankovic M (2007) Analysis of the protein and glycan parts of CA125 antigen from human amniotic fluid. Arch Biol Sci 59:97–103
Kobata A, Endo T (2003) Immobilized lectin columns: useful tools for the fractionation and structural analysis of oligosacchraides. J Chromatogr 597:111–122
Goodell CAR, Belisle JA, Gubbels JAA et al (2009) Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies. J Ovar Res 2:8
Jankovic MM, Milutinovic BS (2008) Glycoforms of CA125 antigen as a possible cancer marker. Cancer Biomark 4:35–42
Gubbels JAA, Belisle J, Onda M et al (2006) Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Molecular Cancer 5:50
Kaneko O, Gong L, Zhang J (2009) A binding domain on mesothelin for CA125/MUC16. J Biol Chem 284:3739–3749
Jankovic MM, Milutinovic BS (2007) Pregnancy-associated CA125 antigen as mucin: evaluation of ferning morphology. Mol Hum Reprod 13:405–408
Jankovic MM, Tapuskovic BT (2005) Molecular forms and microheterogeneity of the pregnancy-associated CA125 antigen. Hum Rep 20:2632–2638
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bouanène, H., Saibi, W., Mokni, M. et al. Biochemical and Morphological Differences Between CA125 Isolated from Healthy Women and Patients with Epithelial Ovarian Cancer from Tunisian Population. Pathol. Oncol. Res. 18, 325–330 (2012). https://doi.org/10.1007/s12253-011-9448-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-011-9448-x